Table 3. Number Needed to Treat NOAC vs VKA (VKA: VKA Group—NOAC: NOAC Group).
Treatment Groups | NNT | ||
---|---|---|---|
VKA alone | NOAC alone | NOAC vs VKA | |
Effectiveness end-point: CV events | |||
% | 14.6% | 9.9% | 21.1 |
Safety end-point: bleeding | |||
% | 11.4% | 5.5% | 17.2 |
Treatment Groups | NNT | ||
---|---|---|---|
VKA alone | NOAC alone | NOAC vs VKA | |
Effectiveness end-point: CV events | |||
% | 14.6% | 9.9% | 21.1 |
Safety end-point: bleeding | |||
% | 11.4% | 5.5% | 17.2 |